A multi-omics features-based approach integrating immunogenicity and inflammation enhances immunotherapy benefit in clear cell renal cell carcinoma
We propose a TIs-ML prediction model based on multi-omics features that can effectively predict ICB treatment response in ccRCC patients. The model integrates inflammatory and immune features, and its high generalization ability was validated in multiple cohorts. Overall, the TIs-ML approach provides a novel method for guiding precise immunotherapy in ccRCC.
Authors
- N. Q. Wang
- Zhihua Pei
- Hailong Hao (ORCID: https://orcid.org/0009-0000-8526-4053)
- Yiqun Zhang (ORCID: https://orcid.org/0000-0001-8691-7722)
- Feng Han (ORCID: https://orcid.org/0000-0003-0985-980X)
- Yanfeng Xue
- Zhen Chen
- Ling Liu
Institutions
- Tongji University (CN)
- Fujian Medical University (CN)
- Harbin Medical University (CN)
- Xiamen University (CN)
- Huazhong Agricultural University (CN)
- Shanxi Provincial Cancer Hospital (CN)
- Second Affiliated Hospital of Fujian Medical University (CN)
- Cancer Hospital of Chinese Academy of Medical Sciences (CN)
Publication Details
- Journal
- Frontiers in Cell and Developmental Biology
- Published
- 2026-01-20
- DOI
- https://doi.org/10.3389/fcell.2025.1596719
- Primary Topic
- Single-cell and spatial transcriptomics
- Type
- article
- Field-Weighted Citation Impact
- 0.00